Collins Charles Edwin IV 4
4 · ARGAN INC · Filed Apr 22, 2026
Research Summary
AI-generated summary of this filing
ARGAN (AGX) CEO Collins Exercises Options and Sells Shares
What Happened
- Collins Charles Edwin IV (CEO) exercised options to acquire a total of 13,568 shares of ARGAN common stock on April 20–21, 2026 and sold those same shares on the open market the same days. Exercise costs totaled about $539,704 and gross sale proceeds were about $8,404,979 — a difference of roughly $7.87M.
- Breakout by date/lot:
- 2026-04-20: Exercised 2,500 shares at $39.47 ($98,675) and sold 2,500 shares at $610.00 ($1,525,000). (Footnotes F1–F2)
- 2026-04-21: Exercised 5,000 at $36.78 ($183,900), 5,235 at $33.81 ($176,995), 500 at $61.22 ($30,610) and 333 at $148.72 ($49,524) — total 11,068 shares exercised ($441,029) — and sold 11,068 shares at an average $621.61 ($6,879,979). (Footnotes F3–F7)
- This pattern — exercising options and then selling the exact shares the same day — is commonly a cashless exercise or immediate sale of exercised shares (not necessarily a separate open-market buy).
Key Details
- Transaction dates & prices:
- Apr 20, 2026: 2,500 exercised @ $39.47; sold @ $610.00.
- Apr 21, 2026: 11,068 exercised across four option grants @ $33.81–$148.72; sold @ ~$621.61 avg.
- Aggregate: 13,568 shares exercised; exercise cost ≈ $539,704; gross sale proceeds ≈ $8,404,979.
- Shares owned after transaction: Not disclosed in the provided filing excerpt.
- Footnotes: Exercises relate to option awards dated Apr 16, 2020; Apr 18, 2022; Apr 17, 2023; Apr 16, 2024; and Apr 10, 2025 (see F1–F6). Sales were open-market transactions (F2, F7).
- Filing timeliness: Form 4 filed 2026-04-22 for transactions on Apr 20–21, 2026 — this appears to be within the standard two-business-day reporting window.
Context
- For options-related filings: because the exercised shares were sold the same day for the same amounts exercised, these transactions function like cashless exercises — the insider converted option value to cash rather than adding long-term stock exposure. That is a routine executive liquidity event and should be viewed as such (factual, not a judgment on company prospects).
- No indication in the excerpt of a 10b5-1 plan, gifts, or tax-withholding share retention; the filing shows open-market sales following exercise.
Insider Transaction Report
Form 4
ARGAN INCAGX
Collins Charles Edwin IV
CHIEF EXECUTIVE OFFICER, GEMMA
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-04-20$39.47/sh+2,500$98,675→ 32,820 total - Sale
Common Stock
[F2]2026-04-20$610.00/sh−2,500$1,525,000→ 30,320 total - Exercise/Conversion
Common Stock
[F3]2026-04-21$36.78/sh+5,000$183,900→ 35,320 total - Exercise/Conversion
Common Stock
[F4]2026-04-21$33.81/sh+5,235$176,995→ 40,555 total - Exercise/Conversion
Common Stock
[F5]2026-04-21$61.22/sh+500$30,610→ 41,055 total - Exercise/Conversion
Common Stock
[F6]2026-04-21$148.72/sh+333$49,524→ 41,388 total - Sale
Common Stock
[F7]2026-04-21$621.61/sh−11,068$6,879,979→ 30,320 total - Exercise/Conversion
Option to Purchase Common Stock
[F1]2026-04-20$39.47/sh−2,500$98,675→ 12,567 totalExercise: $39.47From: 2024-04-17Exp: 2033-04-17→ Common Stock (2,500 underlying) - Exercise/Conversion
Option to Purchase Common Stock
[F3]2026-04-21$36.78/sh−5,000$183,900→ 7,567 totalExercise: $36.78From: 2023-04-18Exp: 2032-04-18→ Common Stock (5,000 underlying) - Exercise/Conversion
Option to Purchase Common Stock
[F4]2026-04-21$33.81/sh−5,235$176,995→ 2,332 totalExercise: $33.81From: 2021-04-16Exp: 2030-04-16→ Common Stock (5,235 underlying) - Exercise/Conversion
Option to Purchase Common Stock
[F5]2026-04-21$61.22/sh−500$30,610→ 1,832 totalExercise: $61.22From: 2025-04-16Exp: 2034-04-16→ Common Stock (500 underlying) - Exercise/Conversion
Option to Purchase Common Stock
[F6]2026-04-21$148.72/sh−333$49,524→ 1,499 totalExercise: $148.72From: 2026-04-10Exp: 2035-04-10→ Common Stock (333 underlying)
Footnotes (7)
- [F1]On April 20, 2026, the Reporting Person exercised his stock option awarded on April 17, 2023 to purchase 2,500 shares of the Issuer's common stock at a price of $39.47 per share.
- [F2]On April 20, 2026, the Reporting Person sold 2,500 shares of the Issuer's common stock on the open market at a price of $610 per share.
- [F3]On April 21, 2026, the Reporting Person exercised his stock option awarded on April 18, 2022 to purchase 5,000 shares of the Issuer's common stock at a price of $36.78 per share.
- [F4]On April 21, 2026, the Reporting Person exercised the remaining portion of his stock option awarded on April 16, 2020 to purchase 5,235 shares of the Issuer's common stock at a price of $33.81 per share.
- [F5]On April 21, 2026, the Reporting Person exercised a portion of his stock option awarded on April 16, 2024 to purchase 500 shares of the Issuer's common stock at a price of $61.22 per share.
- [F6]On April 21, 2026, the Reporting Person exercised a portion of his stock option awarded on April 10, 2025 to purchase 333 shares of the Issuer's common stock at a price of $148.72 per share.
- [F7]On April 21, 2026, the Reporting Person sold 11,068 shares of the Issuer's common stock on the open market at an average price of $621.61 per share.
Signature
/s/ Charles E. Collins IV|2026-04-22